What is the difference between the genome and the transcriptome?

The genome is the (largely fixed) DNA sequence of an organism, whereas the transcriptome is the set of RNA transcripts actually being made at a given time and place. The transcriptome therefore varies by cell type, condition, and state, making it a dynamic readout of gene activity.

Why has RNA sequencing largely replaced microarrays for many studies?

RNA sequencing measures transcripts directly rather than by hybridization to fixed probes, so it can detect novel transcripts and isoforms, offers a wider dynamic range, and does not depend on prior knowledge of which sequences to probe. Microarrays remain useful where a defined probe set and lower cost are sufficient.

Transcriptomics and Gene Expression Analysis

Transcriptomics is the study of the transcriptome — the complete set of RNA transcripts produced by a genome under particular conditions — and gene expression analysis is the family of methods used to measure which genes are transcribed, how much, and in which cells. Because the genome is largely fixed while expression varies across tissues, developmental stages, and disease states, the transcriptome is a dynamic readout of how genotype is translated into cellular function.

Definition

Transcriptomics and gene expression analysis comprise the technologies and analytic methods for cataloguing and quantifying RNA transcripts in cells, tissues, or organisms, in order to characterize gene activity and its regulation.

Scope

This area orients the reader to how RNA abundance is measured and interpreted. It spans the principal measurement platforms (microarrays and high-throughput RNA sequencing), the mapping of genetic variants to expression (expression quantitative trait loci), resolution at the level of individual cells and tissue position (single-cell and spatial transcriptomics), and the regulatory layers of alternative splicing and non-coding RNA. It treats these as methodological and conceptual topics within genomics, not as clinical guidance.

Sub-topics

Core questions

Which genes are expressed in a given cell or tissue, and at what level?
How does expression differ between conditions, such as healthy versus diseased states?
How do genetic variants and regulatory elements shape transcript abundance and structure?
How is expression organized at the resolution of single cells and spatial position within tissue?

Key concepts

Transcriptome
Differential gene expression
Hybridization-based measurement (microarrays)
Sequencing-based measurement (RNA-seq)
Read counting and normalization
Expression quantitative trait loci (eQTL)
Single-cell and spatial resolution
Alternative splicing and non-coding RNA

Mechanisms

Gene expression is measured either by hybridizing labelled transcripts to complementary probes on an array, which yields a relative fluorescence signal per probe, or by reverse-transcribing and sequencing RNA fragments and counting the reads that map to each gene or transcript. Microarrays compare expression against a fixed probe set, whereas RNA sequencing samples transcripts directly, allowing discovery of novel transcripts, isoforms, and splice junctions and a wider dynamic range. Downstream analysis normalizes for differences in sequencing depth and composition, then tests for differential abundance between conditions; the same read-level data can be partitioned by genetic variant (eQTL mapping), by individual cell (single-cell RNA-seq), or by spatial coordinate (spatial transcriptomics).

Clinical relevance

Expression profiling underlies molecular taxonomies of disease — for example, transcriptional subtypes of tumours — and is the basis of several research and diagnostic gene-expression assays. As a reference area it explains how RNA-level evidence is generated and interpreted; it describes methods of inquiry and is not a basis for individual diagnostic or treatment decisions.

Evidence & guidelines

The methodological literature is anchored by foundational platform papers (Schena and colleagues' 1995 cDNA microarray; the RNA-seq reviews of Wang and colleagues) and by large reference resources such as the ENCODE encyclopedia of functional DNA elements and the GTEx atlas of tissue-level regulatory effects, which together define current standards for measuring and interpreting human gene expression.

History

Expression measurement moved from low-throughput methods such as Northern blotting toward genome-scale profiling in the mid-1990s, when complementary DNA and oligonucleotide microarrays allowed thousands of genes to be monitored at once. In the late 2000s, high-throughput sequencing reframed the field as RNA-seq, which counts transcripts directly and resolves isoform structure. Subsequent advances pushed resolution down to single cells and out to spatial position within tissues, while consortium projects such as ENCODE and GTEx built reference maps of expression and its genetic control.

Key figures

Patrick O. Brown
Mark Gerstein
Michael Snyder
Barbara Wold

Seminal works

schena-1995
wang-2009
encode-2012
gtex-2020

Frequently asked questions

What is the difference between the genome and the transcriptome?: The genome is the (largely fixed) DNA sequence of an organism, whereas the transcriptome is the set of RNA transcripts actually being made at a given time and place. The transcriptome therefore varies by cell type, condition, and state, making it a dynamic readout of gene activity.
Why has RNA sequencing largely replaced microarrays for many studies?: RNA sequencing measures transcripts directly rather than by hybridization to fixed probes, so it can detect novel transcripts and isoforms, offers a wider dynamic range, and does not depend on prior knowledge of which sequences to probe. Microarrays remain useful where a defined probe set and lower cost are sufficient.